Certificate of Analysis
GLP-RETA
Triple GIP / GLP-1 / Glucagon receptor agonist
Retatrutide 10mg
Third-party lab report: identity, purity, and endotoxin. Opens the full PDF.
About GLP-RETA
Reta (Research Grade, RUO) is a 39–amino acid unimolecular peptide engineered as a triple agonist of the GIP, GLP-1, and glucagon (GCG) receptors. A C20 fatty diacid moiety supports albumin binding and extended stability in pharmacokinetic models.
Each lot is supplied as a lyophilized white powder at ≥99% HPLC purity with endotoxin <1.0 EU/mg, suitable for metabolic, obesity, T2D, and hepatic-defatting research models.
For Research Use Only (RUO). Not for human or veterinary use.
Specifications
- Purity
- ≥99% (HPLC verified)
- Endotoxin
- <1.0 EU/mg
- Form
- Lyophilized white powder
- Solubility
- Sterile or bacteriostatic water
- Storage
- −20 °C, protect from light
- Sequence length
- 39 amino acids
- Mechanism
- Triple GIP / GLP-1 / GCG agonist
For Research Use Only. Not for human or veterinary consumption. Reports are issued per batch by an accredited third-party laboratory.